You are here: Industry Insights > Diabetes

News List

Creative Peptides Added New GLP-1 Peptides for Diabetes Research biospace
January 16, 2018
On January 11, 2018, the leading peptide expert Creative Peptides announced to add new GLP-1 peptides targeting for diabetes research.
Interactive app provides disease management tool for diabetes europeanpharmaceuticalreview
January 12, 2018
Scientists have developed an online interactive app to help motivate patients to be more active in managing their disease…
USPTO Grants Glytec Patent Allowance for Computer-Guided Selection and Dosing of All Diabetes Medica biospace
January 10, 2018
As a market leader in insulin-managed enterprise software solutions, Glytec is extending its intellectual property protection and providing new patent subsidies to solve all diabetes drug optimization issues
Drug for diabetes type 2 shows potential in treating Alzheimer’s biospectrumasia
January 05, 2018
The drug could also enhance levels of a brain growth factor which protects nerve cell functioning, and slows down the rate of nerve cell loss, among other benefits.
FDA Approves Marketing of Sanuwave's Shock Wave Device for Diabetic Foot Ulcers biospace
January 02, 2018
Today, the U.S. Food and Drug Administration (FDA) permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers.
FDA Approves New Type 2 Diabetes Drug From Merck, Pfizer biospace
December 22, 2017
The U.S. Food and Drug Administration approved Merck’s and Pfizer’s Steglatro (ertugliflozin), a sodium-glucose co-transporter 2 (SGLT2)- inhibitor, that will square off against established drugs in the market.
Xultophy® shows significant results for type 2 diabetes patients in real-world setting pharmaasia
December 19, 2017
Xultophy® by Novo Nordisk has been shown to significantly reduced blood sugar levels in people with type 2 diabetes after six months.
FDA approves Admelog, the first follow-on insulin product to treat diabetes europeanpharmaceuticalreview
December 13, 2017
The FDA has approved Admelog, a short-acting insulin indicated to improve control in blood sugar levels in diabetes…
Novo Nordisk unveils hard-hitting data for two of its diabetes therapies pharmafile
December 06, 2017
Novo Nordisk has lifted the curtain on new data from two of its therapies for diabetes, Xultophy (insulin degludec/liraglutide) and Tresiba, demonstrating the benefits they can provide to patients.
Microbial contamination forces Sun Pharma to recall two lots of diabetes drug in US pharmaceutical-business-review
November 28, 2017
Sun Pharmaceutical Industries is voluntarily recalling two lots of diabetes drug Riomet in the US due to microbial contamination.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page